214 related articles for article (PubMed ID: 15029877)
1. New intragenic deletions in the Phex gene clarify X-linked hypophosphatemia-related abnormalities in mice.
Lorenz-Depiereux B; Guido VE; Johnson KR; Zheng QY; Gagnon LH; Bauschatz JD; Davisson MT; Washburn LL; Donahue LR; Strom TM; Eicher EM
Mamm Genome; 2004 Mar; 15(3):151-61. PubMed ID: 15029877
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of human PHEX under the human beta-actin promoter does not fully rescue the Hyp mouse phenotype.
Erben RG; Mayer D; Weber K; Jonsson K; Jüppner H; Lanske B
J Bone Miner Res; 2005 Jul; 20(7):1149-60. PubMed ID: 15940367
[TBL] [Abstract][Full Text] [Related]
3. A mouse model with postnatal endolymphatic hydrops and hearing loss.
Megerian CA; Semaan MT; Aftab S; Kisley LB; Zheng QY; Pawlowski KS; Wright CG; Alagramam KN
Hear Res; 2008 Mar; 237(1-2):90-105. PubMed ID: 18289812
[TBL] [Abstract][Full Text] [Related]
4. Aberrant Phex function in osteoblasts and osteocytes alone underlies murine X-linked hypophosphatemia.
Yuan B; Takaiwa M; Clemens TL; Feng JQ; Kumar R; Rowe PS; Xie Y; Drezner MK
J Clin Invest; 2008 Feb; 118(2):722-34. PubMed ID: 18172553
[TBL] [Abstract][Full Text] [Related]
5. Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice.
Liu S; Tang W; Zhou J; Vierthaler L; Quarles LD
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1636-44. PubMed ID: 17848631
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Phex in osteoblasts fails to rescue the Hyp mouse phenotype.
Liu S; Guo R; Tu Q; Quarles LD
J Biol Chem; 2002 Feb; 277(5):3686-97. PubMed ID: 11713245
[TBL] [Abstract][Full Text] [Related]
7. [Effect of Connexin on Cochlear Blood-Labyrinth Barrier in a Mouse Model of Endolymphatic Hydrops].
Chen JH; Jiang Y; Zhou L; Long LL; Tang YD
Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Mar; 53(2):291-296. PubMed ID: 35332732
[TBL] [Abstract][Full Text] [Related]
8. Mutation in Phex gene predisposes BALB/c-Phex(Hyp-Duk)/Y mice to otitis media.
Han F; Yu H; Li P; Zhang J; Tian C; Li H; Zheng QY
PLoS One; 2012; 7(9):e43010. PubMed ID: 23028440
[TBL] [Abstract][Full Text] [Related]
9. A novel Phex mutation in a new mouse model of hypophosphatemic rickets.
Owen C; Chen F; Flenniken AM; Osborne LR; Ichikawa S; Adamson SL; Rossant J; Aubin JE
J Cell Biochem; 2012 Jul; 113(7):2432-41. PubMed ID: 22573557
[TBL] [Abstract][Full Text] [Related]
10. Pex gene deletions in Gy and Hyp mice provide mouse models for X-linked hypophosphatemia.
Strom TM; Francis F; Lorenz B; Böddrich A; Econs MJ; Lehrach H; Meitinger T
Hum Mol Genet; 1997 Feb; 6(2):165-71. PubMed ID: 9063736
[TBL] [Abstract][Full Text] [Related]
11. An ethyl-nitrosourea-induced point mutation in phex causes exon skipping, x-linked hypophosphatemia, and rickets.
Carpinelli MR; Wicks IP; Sims NA; O'Donnell K; Hanzinikolas K; Burt R; Foote SJ; Bahlo M; Alexander WS; Hilton DJ
Am J Pathol; 2002 Nov; 161(5):1925-33. PubMed ID: 12414538
[TBL] [Abstract][Full Text] [Related]
12. Evidence for Phex haploinsufficiency in murine X-linked hypophosphatemia.
Wang L; Du L; Ecarot B
Mamm Genome; 1999 Apr; 10(4):385-9. PubMed ID: 10087298
[TBL] [Abstract][Full Text] [Related]
13. Developmental expression and tissue distribution of Phex protein: effect of the Hyp mutation and relationship to bone markers.
Ruchon AF; Tenenhouse HS; Marcinkiewicz M; Siegfried G; Aubin JE; DesGroseillers L; Crine P; Boileau G
J Bone Miner Res; 2000 Aug; 15(8):1440-50. PubMed ID: 10934642
[TBL] [Abstract][Full Text] [Related]
14. Coordinated maturational regulation of PHEX and renal phosphate transport inhibitory activity: evidence for the pathophysiological role of PHEX in X-linked hypophosphatemia.
Nesbitt T; Fujiwara I; Thomas R; Xiao ZS; Quarles LD; Drezner MK
J Bone Miner Res; 1999 Dec; 14(12):2027-35. PubMed ID: 10620061
[TBL] [Abstract][Full Text] [Related]
15. Proteolytic processing of osteopontin by PHEX and accumulation of osteopontin fragments in Hyp mouse bone, the murine model of X-linked hypophosphatemia.
Barros NM; Hoac B; Neves RL; Addison WN; Assis DM; Murshed M; Carmona AK; McKee MD
J Bone Miner Res; 2013 Mar; 28(3):688-99. PubMed ID: 22991293
[TBL] [Abstract][Full Text] [Related]
16. Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice.
Sitara D; Razzaque MS; Hesse M; Yoganathan S; Taguchi T; Erben RG; Jüppner H; Lanske B
Matrix Biol; 2004 Nov; 23(7):421-32. PubMed ID: 15579309
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9-mediated mutation of PHEX in rabbit recapitulates human X-linked hypophosphatemia (XLH).
Sui T; Yuan L; Liu H; Chen M; Deng J; Wang Y; Li Z; Lai L
Hum Mol Genet; 2016 Jul; 25(13):2661-2671. PubMed ID: 27126636
[TBL] [Abstract][Full Text] [Related]
18. Effect of gene dose and parental origin on bone histomorphometry in X-linked Hyp mice.
Qiu ZQ; Travers R; Rauch F; Glorieux FH; Scriver CR; Tenenhouse HS
Bone; 2004 Jan; 34(1):134-9. PubMed ID: 14751570
[TBL] [Abstract][Full Text] [Related]
19. The X chromosome deletion in HYP mice extends into the intergenic region but does not include the SAT gene downstream from Phex.
Sabbagh Y; Gauthier C; Tenenhouse HS
Cytogenet Genome Res; 2002; 99(1-4):344-9. PubMed ID: 12900584
[TBL] [Abstract][Full Text] [Related]
20. A mosaic mutation of phosphate-regulating gene with homologies to endopeptidases on the X chromosome (PHEX) in X-linked hypophosphatemic rickets with mild bone phenotypes.
Asano S; Sako S; Funasaki Y; Takeshita Y; Niida Y; Takamura T
Endocr J; 2021 Sep; 68(9):1135-1141. PubMed ID: 33907069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
